home / stock / swkh / swkh news


SWKH News and Press, SWK Holdings Corporation From 11/11/22

Stock Information

Company Name: SWK Holdings Corporation
Stock Symbol: SWKH
Market: OTC
Website: swkhold.com

Menu

SWKH SWKH Quote SWKH Short SWKH News SWKH Articles SWKH Message Board
Get SWKH Alerts

News, Short Squeeze, Breakout and More Instantly...

SWKH - SWK Holdings Corporation (SWKH) Q3 2022 Earnings Call Transcript

SWK Holdings Corporation (SWKH) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Jason Rando - Executive Vice President & Chief Operating Officer, Tiberend Strategic Advisors Jody Staggs - President & Interim Chief Executive...

SWKH - SWK Holdings GAAP EPS of $0.51 in-line, revenue of $13.6M

SWK Holdings press release ( NASDAQ: SWKH ): Q3 GAAP EPS of $0.51 in-line. Revenue of $13.6M (+42.3% Y/Y). Closed three new transactions during the quarter, totaling $57.5M of committed capital. Book value per share was $21.62 as of September 30, 2022, compared to ...

SWKH - SWK Holdings Corporation Announces Financial Results for Third Quarter 2022

SWK Holdings Corporation Announces Financial Results for Third Quarter 2022 PR Newswire Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET Corporate Highlights Successful leadership transition wit...

SWKH - SWK Holdings Corporation to Report Third Quarter 2022 Financial Results

SWK Holdings Corporation to Report Third Quarter 2022 Financial Results PR Newswire Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022 , at 10:00 a.m. ET DALLAS , Nov. 8, 2022 /PRNewswire/ -- SWK Holding...

SWKH - Stanley Black & Decker To Present At The Baird 2022 Industrial Conference

Stanley Black & Decker To Present At The Baird 2022 Industrial Conference Stanley Black & Decker To Present At The Baird 2022 Industrial Conference PR Newswire NEW BRITAIN, Conn. , Nov. 2, 2022 /PRNewswire/ -- Stanley Black & Decker ...

SWKH - Enteris BioPharma Presents Study of Ovarest® Demonstrating Oral Delivery Comparable to or Exceeding Injectable Leuprolide

Enteris BioPharma Presents Study of Ovarest® Demonstrating Oral Delivery Comparable to or Exceeding Injectable Leuprolide PR Newswire Oral Presentation Delivered at the American Society for Reproductive Medicine Scientific (ASRM) 2022 Congress & Expo ...

SWKH - SWK Holdings unit receives $5M payment from Cara Therapeutics

Life sciences focused specialty finance company SWK Holdings ( NASDAQ: SWKH ) said its unit Enteris BioPharma received a $5M clinical progression milestone payment from Cara Therapeutics ( NASDAQ: CARA ). The payment relates to a license agreement for the comp...

SWKH - SWK Holdings Enhances Executive Management Team and Expands Underwriting Team

SWK Holdings Enhances Executive Management Team and Expands Underwriting Team PR Newswire Yvette Heinrichson promoted to Chief Financial Officer John David Tamas promoted to Director of Underwriting DALLAS , Oct. 3, 2022 /PRNewswir...

SWKH - Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides

Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides PR Newswire Physicochemical properties of peptides can provide key insights to potential success of oral delivery BOONTON, N.J. , Se...

SWKH - SWK Holdings to Participate in Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6"

SWK Holdings to Participate in Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6" PR Newswire DALLAS , Sept. 7, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finan...

Previous 10 Next 10